EFFECTS OF INTRAPORTAL PROSTAGLANDIN E1 ADMINISTRATION ON HEPATIC FUNCTION DURING AND AFTER CIRRHOTIC LIVER RESECTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA